Structure (Alfuzosin 01)
Alfuzosin Hydrochloride Tablet, Extended Release
Product Images NDC 60505-2850
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Alfuzosin Hydrochloride (NDC 60505-2850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-2 (Alfuzosin 03)
Figure-3 (Alfuzosin 04)
Figure-4 (Alfuzosin 05)
Not available.*
Figure-5 (Alfuzosin 06)
Figure-6 (Alfuzosin 07)
Figure-7 (Alfuzosin 08)
Bottle 90s
Each tablet contains 10 mg of Alfuzosin Hydrochloride. The tablets should be stored at a temperature between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). They should be dispensed in a tight, light-resistant container and protected from light and moisture. The usual dosage is described in the package insert. The product is a 10 mg extended-release tablet of Alfuzosin Hydrochloride. The manufacturer is Apotex Corp, based in Toronto, Ontario, Canada. The tablets are available in a pack size of 90 tablets with the National Drug Code (NDC) number 60505-2850-9. The pharmacist should dispense the tablets with a patient information leaflet, which can be found on the Apotex website at www.apotex.com/products/umg.asp.*
Figure-1 (Uroxatral Image02)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
